Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression

Blanco-Gomez, A; Hontecillas-Prieto, L; Corchado-Cobos, R; Garcia-Sancha, N; Salvador, N; Castellanos-Martin, A; Saez-Freire, MD; Mendiburu-Elicabe, M; Alonso-Lopez, D; De Las Rivas, J; Lorente, M; Garcia-Casas, A; Del Carmen, S; Abad-Hernandez, MD; Cruz-Hernandez, JJ; Rodriguez-Sanchez, CA; Claros-Ampuero, J; Garcia-Cenador, B; Garcia-Criado, J; Orimo, A; Gridley, T; Perez-Losada, J; Castillo-Lluva, S

Perez-Losada, J (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc IBMCC CIC, Salamanca, Spain.; Castillo-Lluva, S (corresponding author), Univ Complutense, Dept Bioquim & Biol Mol, Madrid 28040, Spain.; Castillo-Lluva, S (corresponding author), Univ Complutense, Fac Ciencias Quim, Madrid 28040, Spain.

CANCER RESEARCH, 2020; 80 (23): 5216

Abstract

SNAI2 overexpression appears to be associated with poor prognosis in breast cancer, yet it remains unclear in which breast cancer subtypes this occurs......

Full Text Link